Isabelle Tigaud
About
In The Last Decade
Isabelle Tigaud
63 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 80
- Hematology 1.0k
- Molecular Biology 732
- Genetics 494
- Public Health, Environmental and Occupational Health 316
- Oncology 219
Countries citing papers authored by Isabelle Tigaud
This map shows the geographic impact of Isabelle Tigaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Tigaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Tigaud more than expected).
Fields of papers citing papers by Isabelle Tigaud
This network shows the impact of papers produced by Isabelle Tigaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Tigaud. The network helps show where Isabelle Tigaud may publish in the future.
Co-authorship network of co-authors of Isabelle Tigaud
This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Tigaud. A scholar is included among the top collaborators of Isabelle Tigaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Tigaud. Isabelle Tigaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 22 | |
| 5 | 9 | |
| 6 | 40 | |
| 7 | 49 | |
| 8 | 3 | |
| 9 | 7 | |
| 10 | 24 | |
| 11 | 38 | |
| 12 | 9 | |
| 13 | Flt3 and MLL internal tandem duplications and topoisomerase II breakages reflect a common category of genotoxic stress: An EORTC study | 2 |
| 14 | 86 | |
| 15 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 1 |
| 16 | Are AClonal@ X-chromosome inactivation patterns of T cells in MDS dependent on disease duration ? Evaluation of 117 patients with MDS | 1 |
| 17 | Analysis of clonality by HUMARA PCR in high risk MDS patients before and after intensive anti-leukemic treatment | 1 |
| 18 | 116 | |
| 19 | 22 | |
| 20 | Remaniement de la bande chromosomique 11q23 dans les hémopathies malignes | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.